Latest Press Releases Number of shares and voting rights of Innate Pharma as of April 25, 2025 April 28, 2025 Innate Pharma announces €15m investment by Sanofi April 24, 2025 Innate Pharma regains its rights on CD123 targeting ANKET® and announces Sanofi’s intention to make a strategic investment in the Company April 23, 2025 Selected media Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma Mon, 12/09/2024 - 00:00 Read more about Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma ANKET: Our NK cell engager platform Thu, 06/10/2021 - 07:00 Click here to learn more about ANKETTM Read more about ANKET: Our NK cell engager platform Interview of Eric Vivier “The new generation of NK cell therapies” Fri, 02/05/2021 - 08:00 Interview Eric Vivier "The new generation of NK cell therapies" Read more about Interview of Eric Vivier “The new generation of NK cell therapies”
Innate Pharma regains its rights on CD123 targeting ANKET® and announces Sanofi’s intention to make a strategic investment in the Company April 23, 2025
Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma Mon, 12/09/2024 - 00:00 Read more about Trois questions à Jonathan Dickinson, Président du Directoire d'Innate Pharma
ANKET: Our NK cell engager platform Thu, 06/10/2021 - 07:00 Click here to learn more about ANKETTM Read more about ANKET: Our NK cell engager platform
Interview of Eric Vivier “The new generation of NK cell therapies” Fri, 02/05/2021 - 08:00 Interview Eric Vivier "The new generation of NK cell therapies" Read more about Interview of Eric Vivier “The new generation of NK cell therapies”
